G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GTHX | AMGN | VRTX | GILD | BMY |
| Company | G1 Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 7.15 | 336.74 | 440.02 | 124.81 | 48.27 |
| High | 7.16 | 339.80 | 442.22 | 125.64 | 48.37 |
| Low | 7.14 | 330.35 | 433.67 | 122.50 | 46.12 |
| Last | 7.15 | 336.74 | 437.15 | 125.02 | 46.65 |
| Change | unch | +0.74 | +2.63 | -0.18 | -1.98 |
| % Change | unch | +0.22% | +0.61% | -0.14% | -4.07% |
| Volume | 1,267,000 | 3,310,300 | 1,264,900 | 6,599,500 | 19,779,200 |
| 20-Day Average Volume | 1,686,815 | 2,613,435 | 1,412,620 | 6,857,210 | 16,394,439 |
| Previous Close | 7.15 | 336.00 | 434.52 | 125.20 | 48.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 7.12 | 308.52 | 423.39 | 121.48 | 45.62 |
| 20-Day Raw Stochastic | 60.00% | 84.27% | 87.02% | 80.53% | 55.29% |
| 20-Day Relative Strength | 81.57 | 71.84 | 62.00 | 60.63 | 53.55 |
| Weighted Alpha | +144.60 | +24.83 | -3.64 | +40.38 | -16.14 |
| Today's Opinion | 100% Buy | 100% Buy | 8% Buy | 100% Buy | 24% Sell |
| Previous Opinion | 100% Buy | 100% Buy | 8% Buy | 100% Buy | 8% Sell |
| Last Month's Opinion | 72% Buy | 24% Buy | 40% Sell | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 09/10/24 | +5.17% since 11/07/25 | +6.76% since 11/07/25 | +5.20% since 11/07/25 | -0.09% since 11/07/25 |
| Low | 7.12 on 09/12/24 | 319.54 on 11/10/25 | 410.50 on 11/10/25 | 117.13 on 11/10/25 | 46.12 on 11/14/25 |
| High | 7.16 on 09/17/24 | 345.84 on 11/13/25 | 442.22 on 11/14/25 | 127.68 on 11/13/25 | 49.99 on 11/13/25 |
| 1-Month | |||||
| %Chg | +0.56% since 08/16/24 | +14.60% since 10/14/25 | +6.05% since 10/14/25 | +5.52% since 10/14/25 | +6.51% since 10/14/25 |
| Low | 7.08 on 08/19/24 | 288.00 on 10/31/25 | 403.16 on 11/04/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 7.19 on 08/27/24 | 345.84 on 11/13/25 | 442.22 on 11/14/25 | 127.68 on 11/13/25 | 49.99 on 11/13/25 |
| 3-Month | |||||
| %Chg | +167.79% since 06/17/24 | +16.00% since 08/14/25 | +12.00% since 08/14/25 | +5.04% since 08/14/25 | -2.43% since 08/14/25 |
| Low | 1.44 on 06/24/24 | 269.77 on 09/26/25 | 374.17 on 09/24/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 7.19 on 08/27/24 | 345.84 on 11/13/25 | 442.22 on 11/14/25 | 127.68 on 11/13/25 | 49.99 on 11/13/25 |
| 6-Month | |||||
| %Chg | +129.90% since 03/15/24 | +28.39% since 05/14/25 | +3.80% since 05/14/25 | +27.08% since 05/14/25 | +5.73% since 05/14/25 |
| Low | 1.44 on 06/24/24 | 264.15 on 05/15/25 | 362.50 on 08/11/25 | 97.86 on 05/15/25 | 42.52 on 10/29/25 |
| High | 7.19 on 08/27/24 | 345.84 on 11/13/25 | 484.56 on 07/10/25 | 127.68 on 11/13/25 | 50.76 on 06/11/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 373,809 | 181,328,096 | 110,913,264 | 155,109,824 | 94,967,880 |
| Shares Outstanding, K | 52,281 | 538,481 | 253,719 | 1,240,680 | 2,035,753 |
| Annual Sales | 82,510,000 | 33,424,000,000 | 11,020,100,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -47,970,000 | 4,090,000,000 | -535,600,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 16,550,000 | 9,557,000,000 | 3,076,400,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -5,470,000 | 3,216,000,000 | 1,082,900,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 1.66 | 0.45 | 0.36 | 0.32 | 0.33 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 08/08/24 | 5.64 on 11/04/25 | 4.80 on 11/03/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 |
| Latest Earnings Date | 11/06/24 | 11/04/25 | 11/03/25 | 10/30/25 | 10/30/25 |
| Most Recent Dividend | N/A | 2.380 on 08/22/25 | N/A | 0.790 on 09/15/25 | 0.620 on 10/03/25 |
| Next Ex-Dividends Date | N/A | 11/21/25 | N/A | 12/15/25 | 10/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.36 | 28.38 | 15.29 | 7.41 |